Yahoo Web Search

Search results

1. www.genmab.comWelcome to Genmab

   www.genmab.com

   • Cached

   Genmab is a leading biotech company that develops and commercializes antibody medicines for cancer and other serious diseases. Learn about their products, science, partnerships, investors, news and career opportunities.

   • Careers

     “Genmab is a science-driven company,” Barbara says. “We’re...

   • Pipeline

     Genmab is developing innovative antibody-based therapeutics...

   • Transforming The Future of Antibody-Based Cancer Treatment

     Genmab, our. medicines, research findings, and more. Genmab...

     Check out our history

     · Take a peek at the future

     · Join our mission

     · Sign Up

     · Compliance and Disclosures

     · Legal Notice

   • Investors

     Founded in Copenhagen, Denmark in 1999, Genmab A/S’s...

   • Executive Committee

     Mr. Pagano joined Genmab in 2007, was appointed Senior Vice...

   • Who We Are

     Delivering on our promise for patients. Founded in 1999 in...

     History

     · Board of Directors

   • Medicines

     We would like to show you a description here but the site...

   • Partnering

     In June 2021, Genmab and Bolt entered into an oncology...

   • Locations

     Genmab US, Inc. 777 Scudders Mill Road Plainsboro, NJ 08536...

2. en.wikipedia.org › wiki › GenmabGenmab - Wikipedia

   en.wikipedia.org › wiki › Genmab

   • Cached

   Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen , Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht , The Netherlands , Genmab U.S., Inc. in Princeton ...

3. Videos

   • 

     5:01

     youtube.com

     Antibody Architects

     Mar 6, 2023

     2.2K Views

   • 

     3:49

     youtube.com

     Genmab Receives 2021 Corporate Achievement Award from CancerCare

     May 14, 2021

     951 Views

   • 

     1:5:07

     youtube.com

     Genmab GMAB Q3 2023 Earnings Call & Presentation

     Dec 30, 2023

     85 Views

   View all

4. www.us.genmab.comGenmab US - Transforming the future of cancer treatment

   www.us.genmab.com

   • Cached

   Genmab is a biotech company that creates antibody-based treatments for cancer and other serious diseases. Learn about their unique approach, research, collaboration, and patient support.

5. finance.yahoo.com › news › genmab-completesGenmab Completes Acquisition of ProfoundBio - Yahoo Finance

   finance.yahoo.com › news › genmab-completes

   • Cached

   May 21, 2024 · GNMSF. Genmab has completed acquisition of ProfoundBio for USD 1.8 billion in cash. Acquisition gives Genmab worldwide rights to three candidates in clinical development, including rinatabart ...

6. Top Stories

   • 

     GlobalData on MSN.com

     Genmab acquires biotechnology company ProfoundBio in $1.8bn deal

     7 days ago

   • 

     Business Insider

     What 9 Analyst Ratings Have To Say About Genmab

     1 week ago

   • YAHOO!Finance

     Genmab Completes Acquisition of ProfoundBio

     Genmab A/S (Nasdaq: GMAB) announced today that it has completed its acquisition of ProfoundBio, Inc., a clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADC)s and ADC technologies for the treatment of cancers in an all-cash transaction of USD 1.

     1 week ago

   • YAHOO!Finance

     Transactions in Connection with Share Buy-back Program

     On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5 billion worth of shares.The share buy-back program is expected to be completed no later than December 16,

     2 days ago

   • Business Insider

     Genmab’s Buy Rating Affirmed by Promising Epcoritamab Trials and Regulatory Milestones

     Analyst Ram Selvaraju of H.C. Wainwright reiterated a Buy rating on Genmab (GMAB – Research Report), retaining the price target of

     1 week ago

   View all

7. ir.genmab.com › news-releases › news-release-detailsGenmab Completes Acquisition of ProfoundBio - Genmab A/S

   ir.genmab.com › news-releases › news-release-details

   • Cached

   May 21, 2024 · Company Announcement. Genmab has completed acquisition of ProfoundBio for USD 1.8 billion in cash. Acquisition gives Genmab worldwide rights to three candidates in clinical development, including rinatabart sesutecan (Rina-S), plus ProfoundBio’s novel antibody-drug conjugate technology platforms.

8. www.genmab.com › who-we-areWho We Are | Genmab

   www.genmab.com › who-we-are

   • Cached

   Genmab is a dual-listed, international biotechnology company that develops differentiated antibody medicines to fight against cancer and other serious diseases. Learn about its vision, purpose, values, achievements, pipeline, science and career opportunities.

9. www.genmab.com › pipelineGlobal Pipeline | Genmab

   www.genmab.com › pipeline

   • Cached

   Genmab is a biotechnology company that develops innovative antibody-based medicines for various indications. Learn about its products, technologies, and clinical trials in different stages of development.

10. People also ask

    What does Genmab do?

    • of antibody-based treatments Join our mission to improve the lives of patients medicines, research findings, and more. Genmab is a biotech company that creates antibody-based treatments for cancer and other serious diseases.

    Transforming the Future of Antibody-Based Cancer Treatment | Genmab …

    www.us.genmab.com/

    See all results for this question

    Where is Genmab based?

    • The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, USA, and Genmab K.K. in Tokyo, Japan.

    Genmab - Wikipedia

    en.wikipedia.org/wiki/Genmab

    See all results for this question

    Who is Genmab A/S?

    • Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund.

    Genmab - Wikipedia

    en.wikipedia.org/wiki/Genmab

    See all results for this question

    How did Genmab start?

    • Genmab was founded as a European spin-off of American Biotech company Medarex in February 1999. Danish investment firm BankInvest, under Florian Schönharting, provided the seed investment for the company to start up in Copenhagen. Like Medarex, Genmab began work producing monoclonal antibodies for life-threatening or debilitating diseases.

    Genmab - Wikipedia

    en.wikipedia.org/wiki/Genmab

    See all results for this question